Related Experiment Video
Updated: May 6, 2026
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Skin viscoelasticity during hormone replacement therapy for climacteric ageing
G E Piérard1, T Hermanns-Lê1, P Paquet1
1Laboratory of Skin Bioengineering and Imaging (LABIC), Department of Clinical Sciences, B23, University of Liège, B-4000, Liège, Belgium.
Background:
Climacteric ageing refers to the period of women's life centred by the perimenopause. This step of life is responsible for initiating skin atrophic withering and slackness responsible for changes in the viscoelasticity of the dermal connective tissue. Some women benefit from hormone replacement therapy (HRT) for controlling some unpleasant internal climacteric changes (osteoporosis, vasomotor instability, …).
Objective:
To investigate some corrective effects of HRT on the functional damages in the dermal tensile strength.
Patients And Methods:
This study was performed on 200 healthy Caucasian women. In vivo skin viscoelasticity was assessed using the suction method.
Results:
Skin distensibility and hysteresis appeared increased at menopause with or without HRT. By contrast, the biological elasticity significantly decreased out of HRT.
Conclusion:
Some drugs and cosmetics might attempt at improving such viscoelastic attributes of the skin at menopause.
More Related Videos
14:26A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
Published on: April 7, 2014
13:18How to Study Basement Membrane Stiffness as a Biophysical Trigger in Prostate Cancer and Other Age-related Pathologies or Metabolic Diseases
Published on: September 20, 2016
Related Concept Videos
01:19The Effect of Aging on Tissues
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
01:28Menopause
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:33Hormonal Regulation
01:40Hormonal Regulation